Delivery Order SPE2DR25D3801-SPE2DR26F6QEC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $15,609.03 for 60 tablets of Savella 50 mg. The contract was competitively awarded on July 29, 2025, with a firm fixed price structure and an ultimate completion date of July 30, 2025. This award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, valued at $5,835.91, with an ultimate completion date of October 28, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest pharmaceutical...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- Amerisourcebergen Drug Corp has received a $2,579.11 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 60 Savella 100 mg tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to the place of performance in Conshohocken, Pennsylvania by the completion date of November 7, 2023. A subsidiary of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp provides pharmaceutical products and services...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,309.08 firm fixed price delivery order is for the supply of Savella 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 tablets of the medication Savella 25 mg. The contract, valued at $1,149.00, has a completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,223.37 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 60 tablets of Savella, a 12.5 mg medication, to locations within Conshohocken, Pennsylvania between August 3rd and 4th, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,012.34 from the Defense Logistics Agency (DLA) Troop Support Medical program to supply 4562841026 Savella 50 mg tablets, 60 count, to a location in Conshohocken, Pennsylvania by November 17, 2023. As a prime contractor and subsidiary of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp routinely provides pharmaceutical products and medical supplies to DLA Troop Support Medical facilities in support of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on November 17, 2025, under a firm fixed-price contract. This non-set-aside delivery order is expected to be completed by November 18, 2025, and represents a child contract under the company's larger pharmaceutical supply agreement with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. AmerisourceBergen...
- SPE2DR25D3801Indefinite Delivery Contract
- SPE2DR25D3801-SPE2DR26F6QECDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,153.92 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units). The contract is non-competitive and employs firm fixed-price pricing, with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal defense and veteran healthcare systems. As a prime contractor under DLA's Medical Supply Chain program, the company supplies an extensive portfolio of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's demonstrated capability to fulfill federal procurement requirements through competitive awards, combined with its substantial IDC with DLA, positions it as a key vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning future Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 12/14/25 |